The common pathways affected by inhibition of Toll-like protein in hepatocellular carcinoma cell lines that may play role in doxorubicin resistance

Demir, A. B.Yetkin, S.Alotaibi, H.Atabey, N.Koc, A.2026-04-042026-04-0420232211-5463https://hdl.handle.net/11616/110083[No abstract available]eninfo:eu-repo/semantics/closedAccessThe common pathways affected by inhibition of Toll-like protein in hepatocellular carcinoma cell lines that may play role in doxorubicin resistanceConference Object139293WOS:001401044000263Q3